BIOPOL logo

Biopol Chemicals Limited

BIOPOL·NSE·
₹46.00▼ -0.95 (-2.02%)
Market Cap49.00 Cr
PE Ratio4.25
Volume32,400
Day High - Low46.00 - 45.00
52W High-Low133.75 - 39.50

Biopol Chemicals Limited (BIOPOL): company summary

Biopol Chemicals Limited's business has improved significantly, with annual revenue rising 65.2% and net profit growing 106.7% year-on-year.

Biopol Chemicals Limited (BIOPOL) is a micro-cap Chemicals company valued at ₹49 crore operating in Specialty Chemicals on the NSE and BSE.

Recent price move
Biopol Chemicals Limited last traded at ₹46, down 2.02% on the day.
Recent developments
On 2026-06-30, promoter holding remained at 65.81%, with no significant changes reported. Foreign institutional holding decreased by 4.60 percentage points to 4.70%, and domestic institutional holding fell by 2.38 percentage points to 0.54%. The company has not paid dividends despite reporting profits.
Financial performance
Biopol Chemicals Limited's business has improved significantly, with annual revenue rising 65.2% and net profit growing 106.7% year-on-year. However, the latest quarter saw revenue fall 42.5% compared to the same quarter a year earlier, while net profit remained flat at 0.7%. The net profit margin expanded by 2.2 percentage points to 11.1%, and return on equity remained steady at 18.0%.
Valuation multiples
The stock trades at 4.3 times earnings, 1.02 times book value.
Things to watch
The stock is 61.6% below its 52-week high, indicating a significant drop from recent peak levels. Foreign institutional holding has declined sharply, and domestic institutional holding has also fallen. The company has not distributed any dividends to shareholders despite reporting profits.
Where it stands
Biopol Chemicals Limited has shown strong annual growth in revenue and net profit, but the latest quarter's performance was weak. The company's net profit margin has improved, and return on equity remains stable. However, the stock is far below its 52-week high, and institutional holdings have declined.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score
6.0/10
Fair
Fair Value
Sign in to see
ROE
17.98%
Strong
P/E
4.25x
Cheap
Debt / Equity
0.17
Low
Industry
Chemicals
Specialty Chemicals
Overall View
Mixed

Price performance

Day₹45.00
₹46.00
52W₹39.50
₹133.75
DocStoX take

Supported by valuation (9.0) and risk (8.0), but held back by momentum (0.0). Valuation looks strong at 9.0, but that is offset by momentum at 0.0. We are calling it Mixed rather than resolving the conflict for you. Scored on 4 of 5 measures.

DocStoX score

Low confidence
6.0
/10
Fair
Quality
Solid
ROE 18.0%
Valuation
Cheap
P/E 4.3×
Growth
No data
No multi-year history
Risk
Low risk
D/E 0.17
Momentum
Weak
7% of 52-week range

Scored on 4 of 5 measures — the rest have no data for this company.

At a glance

Market Cap
₹49 Cr
52W High / Low
₹134 / ₹40
Dividend Yield
0.00%
Promoter Holding
65.81%
EPS (TTM)
₹10.83
Book Value
₹63.10

Key highlights

  • Low leverage — D/E 0.17
  • Undemanding at 4× earnings
  • Capital works hard — ROCE 23%
  • Momentum is weak (0.0/10)
  • Near the bottom of its 52-week range (7%)
3 Positives3 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Chemicals stocks · Specialty Chemicals

BIOPOL CHEMICALS LIMITED peers in Chemicals

Other Chemicals stocks on the NSE & BSE. See the full Chemicals sector list.